• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.老年葡萄糖脑苷脂酶突变携带者的认知和运动功能
Neurobiol Aging. 2017 Oct;58:239.e1-239.e7. doi: 10.1016/j.neurobiolaging.2017.06.010. Epub 2017 Jun 24.
2
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
3
High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.载脂蛋白 E 基因 ε4 等位基因与阿尔茨海默病患者脑内神经原纤维缠结和老年斑的关系
JAMA Neurol. 2016 Dec 1;73(12):1448-1453. doi: 10.1001/jamaneurol.2016.1593.
4
Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.帕金森病和路易体痴呆中的葡萄糖脑苷脂酶突变与神经精神表型:综述与荟萃分析
Am J Med Genet B Neuropsychiatr Genet. 2018 Mar;177(2):232-241. doi: 10.1002/ajmg.b.32549. Epub 2017 May 26.
5
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.GBA 相关帕金森病的生存和痴呆:突变很重要。
Ann Neurol. 2016 Nov;80(5):662-673. doi: 10.1002/ana.24777. Epub 2016 Oct 3.
6
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.伴有和不伴有GBA突变的帕金森病中的葡萄糖脑苷脂酶活性
Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.
7
Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.葡萄糖脑苷脂酶突变是帕金森病的主要遗传风险因素,在一个佛兰德 - 比利时队列中会增加患痴呆症的易感性。
Neurosci Lett. 2016 Aug 26;629:160-164. doi: 10.1016/j.neulet.2016.07.008. Epub 2016 Jul 7.
8
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.GBA 相关帕金森病和路易体痴呆风险和发病年龄的遗传修饰物。
Brain. 2020 Jan 1;143(1):234-248. doi: 10.1093/brain/awz350.
9
Decreased Penetrance of Parkinson's Disease in Elderly Carriers of Glucocerebrosidase Gene L444P/R Mutations: A Community-Based 10-Year Longitudinal Study.载脂蛋白 E ε4 等位基因与帕金森病的相关性:一项基于人群的 10 年纵向研究。
Mov Disord. 2020 Apr;35(4):672-678. doi: 10.1002/mds.27971. Epub 2020 Jan 8.
10
The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews.载脂蛋白 E 多态性和 GBA 突变对阿什肯纳兹犹太人路易体痴呆的影响。
J Alzheimers Dis. 2021;80(3):1221-1229. doi: 10.3233/JAD-201295.

引用本文的文献

1
Synaptic and cognitive impairment associated with L444P heterozygous glucocerebrosidase mutation.与L444P杂合性葡萄糖脑苷脂酶突变相关的突触和认知障碍。
Brain. 2025 May 13;148(5):1621-1638. doi: 10.1093/brain/awae380.
2
Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriers.GBA1和LRRK2突变携带者中胆碱能系统完整性与认知衰退的关联。
NPJ Parkinsons Dis. 2024 Jun 29;10(1):127. doi: 10.1038/s41531-024-00743-w.
3
Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach.谁有患帕金森病的风险?GBAl 和 LRRK2 变异携带者临床前阶段的精细化:临床、生化和影像学方法。
Curr Neurol Neurosci Rep. 2023 Apr;23(4):121-130. doi: 10.1007/s11910-023-01259-1. Epub 2023 Mar 7.
4
Who to Enroll in Parkinson Disease Prevention Trials? The Case for Genetically At-Risk Cohorts.谁应该参加帕金森病预防试验?具有遗传风险队列的案例。
Neurology. 2022 Aug 16;99(7 Suppl 1):10-18. doi: 10.1212/WNL.0000000000200812.
5
Cognitive Functioning of Glucocerebrosidase () Non-manifesting Carriers.葡萄糖脑苷脂酶()非显性携带者的认知功能
Front Neurol. 2021 Feb 26;12:635958. doi: 10.3389/fneur.2021.635958. eCollection 2021.
6
Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease.帕金森病患者临床症状的分层数据驱动分析
Front Neurol. 2019 May 21;10:531. doi: 10.3389/fneur.2019.00531. eCollection 2019.

本文引用的文献

1
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.氨溴索对葡萄糖脑苷脂酶和α-突触核蛋白转基因小鼠的影响。
Ann Neurol. 2016 Nov;80(5):766-775. doi: 10.1002/ana.24790.
2
Neuropsychiatric characteristics of GBA-associated Parkinson disease.GBA相关帕金森病的神经精神特征
J Neurol Sci. 2016 Nov 15;370:63-69. doi: 10.1016/j.jns.2016.08.059. Epub 2016 Aug 30.
3
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.GBA 相关帕金森病的生存和痴呆:突变很重要。
Ann Neurol. 2016 Nov;80(5):662-673. doi: 10.1002/ana.24777. Epub 2016 Oct 3.
4
A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.一项针对未表现出症状的LRRK2和GBA基因携带者的认知功能磁共振成像研究。
Brain Struct Funct. 2017 Apr;222(3):1207-1218. doi: 10.1007/s00429-016-1271-4. Epub 2016 Jul 11.
5
Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.葡萄糖脑苷脂酶突变是帕金森病的主要遗传风险因素,在一个佛兰德 - 比利时队列中会增加患痴呆症的易感性。
Neurosci Lett. 2016 Aug 26;629:160-164. doi: 10.1016/j.neulet.2016.07.008. Epub 2016 Jul 7.
6
Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals.戈谢病患者中帕金森病的前驱临床标志物
Eur Neurol. 2016;76(1-2):19-21. doi: 10.1159/000447510. Epub 2016 Jun 25.
7
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.氨丁三醇共处理治疗神经病变型戈谢病:一项初步研究。
Ann Clin Transl Neurol. 2016 Feb 2;3(3):200-15. doi: 10.1002/acn3.292. eCollection 2016 Mar.
8
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.GBA基因变异与帕金森病中一种独特的认知缺陷模式相关。
Mov Disord. 2016 Jan;31(1):95-102. doi: 10.1002/mds.26359. Epub 2015 Aug 21.
9
Glucocerebrosidase and Parkinson disease: Recent advances.葡萄糖脑苷脂酶与帕金森病:最新进展
Mol Cell Neurosci. 2015 May;66(Pt A):37-42. doi: 10.1016/j.mcn.2015.03.013. Epub 2015 Mar 20.
10
Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.戈谢病相关的突触核蛋白病:从罕见(疾病)角度审视散发性神经退行性变。
Prog Neurobiol. 2015 Feb;125:47-62. doi: 10.1016/j.pneurobio.2014.12.001. Epub 2015 Jan 6.

老年葡萄糖脑苷脂酶突变携带者的认知和运动功能

Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.

作者信息

Moran Eileen E, Wang Cuiling, Katz Mindy, Ozelius Laurie, Schwartz Alison, Pavlovic Jelena, Ortega Roberto A, Lipton Richard B, Zimmerman Molly E, Saunders-Pullman Rachel

机构信息

Department of Psychology, Fordham University, Bronx, NY, USA.

Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

Neurobiol Aging. 2017 Oct;58:239.e1-239.e7. doi: 10.1016/j.neurobiolaging.2017.06.010. Epub 2017 Jun 24.

DOI:10.1016/j.neurobiolaging.2017.06.010
PMID:28728889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5647652/
Abstract

Mutations in the glucocerebrosidase (GBA) gene are a strong genetic risk factor for the development of Parkinson's disease and dementia with Lewy Bodies. However the penetrance of GBA mutations is low for these diseases in heterozygous carriers. The aim of this study was to examine the relationship between mutation status and cognitive and motor functioning in a sample of community-dwelling older adults. Using linear mixed effects models, we examined the effect of heterozygous mutation status on 736 community-dwelling older adults (≥70 years) without dementia or Parkinson's disease assessed over an average of 6 years, 28 of whom had a single GBA mutation (primarily N370S). Verbal memory was measured using the picture version of the Free and Cued Selective Reminding Test, and carriers showed significantly (p < 0.05) greater decline in verbal memory over time. There was no difference in motor function or any other cognitive domain. Taken together, these results suggest an effect, but an overall limited burden, of harboring a single GBA mutation in aging mutation carriers.

摘要

葡萄糖脑苷脂酶(GBA)基因突变是帕金森病和路易体痴呆发生的一个重要遗传风险因素。然而,对于这些疾病,杂合子携带者中GBA突变的外显率较低。本研究的目的是在一组社区居住的老年人样本中,检验突变状态与认知和运动功能之间的关系。我们使用线性混合效应模型,对736名社区居住的≥70岁、无痴呆或帕金森病的老年人进行了平均6年的评估,其中28人有单个GBA突变(主要是N370S),检验杂合突变状态的影响。使用图片版的自由和提示选择性回忆测验测量言语记忆,携带者随时间推移在言语记忆方面表现出显著(p<0.05)更大的下降。运动功能或任何其他认知领域没有差异。综上所述,这些结果表明,在老年突变携带者中携带单个GBA突变有影响,但总体负担有限。